Residual effect of nCPAP applied for part of the night in patients with obstructive sleep apnoea
Authors:
- M DuryMDM Dury
- G AubertGAG Aubert
Open Access
- 1 May 1997
- journal article
- clinical trial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 10 (5) , 973-976
Abstract
The aim of the present study was to assess whether nasal continuous positive airway pressure (nCPAP) treatment, applied for only a few hours at the beginning of the night, has any residual effect on sleep and breathing during the ensuing hours of unassisted sleep in patients with obstructive sleep apnoea syndrome (OSAS). In 27 patients with newly-diagnosed OSAS, effective nCPAP was applied during the first part of the night and then withdrawn. Polysomnographic parameters after nCPAP withdrawal were compared with those of the corresponding part of the diagnostic polysomnography performed a few days or weeks before and with those of the first part of night on nCPAP. After 255+/-63 (mean+/-SD) min of sleep with normalization of sleep and breathing parameters under nCPAP, there was partial improvement of OSAS severity during the remaining 124+/-56 min of nocturnal sleep without treatment; mean oxygen saturation, desaturation index (equivalent to the apnoea/hypopnoea index) and movement arousal index all improved significantly with respect to the diagnostic night (p=0.001). This improvement was not accounted for by a change in sleep architecture. We conclude that there is an improvement in severity of obstructive sleep apnoea syndrome after only 4 h of nasal continuous positive airway pressure. This carryover effect could explain why a number of patients with obstructive sleep apnoea syndrome apply nasal continuous positive airway pressure for only part of the night or not every night.Keywords
This publication has 17 references indexed in Scilit:
- Movement Arousals and Sleep-Related Disordered Breathing in AdultsAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Effect of chronic continuous positive airway pressure (CPAP) therapy on upper airway size in patients with sleep apnoea/hypopnoea syndrome.Thorax, 1996
- Daytime Sleepiness and Nasal Continuous Positive Airway Pressure Therapy in Obstructive Sleep Apnea Syndrome Patients: Effects of Chronic Treatment and 1-Night Therapy WithdrawalSLEEP, 1995
- Effects of Sleep Deprivation and Sleep Fragmentation on Upper Airway Collapsibility in Normal SubjectsAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome.Thorax, 1994
- Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndromeThe Lancet, 1994
- Nasal CPAP: An Objective Evaluation of Patient ComplianceAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Objective Measurement of Patterns of Nasal CPAP Use by Patients with Obstructive Sleep ApneaAmerican Review of Respiratory Disease, 1993
- Treatment of Obstructive Sleep Apnea with Nasal Continuous Positive Airway Pressure: Patient Compliance, Perception of Benefits, and Side EffectsAmerican Review of Respiratory Disease, 1992
- REVERSAL OF OBSTRUCTIVE SLEEP APNOEA BY CONTINUOUS POSITIVE AIRWAY PRESSURE APPLIED THROUGH THE NARESThe Lancet, 1981